BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14691995)

  • 21. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies.
    Maymon R; Dreazen E; Rozinsky S; Bukovsky I; Weinraub Z; Herman A
    Prenat Diagn; 1999 Nov; 19(11):1007-11. PubMed ID: 10589049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.
    Ognibene A; Ciuti R; Tozzi P; Messeri G
    Prenat Diagn; 1999 Nov; 19(11):1058-60. PubMed ID: 10589060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction.
    Bellver J; Lara C; Soares SR; Ramírez A; Pellicer A; Remohí J; Serra V
    Hum Reprod; 2005 Sep; 20(9):2623-7. PubMed ID: 15905286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated serum screening for Down syndrome in primary obstetric practice.
    Knight GJ; Palomaki GE; Neveux LM; Smith DE; Kloza EM; Pulkkinen AJ; Williams J; Haddow JE
    Prenat Diagn; 2005 Dec; 25(12):1162-7. PubMed ID: 16231402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Second trimester Down syndrome serum screening--results from a pilot study].
    Dimitrova V; Chernev T; Kremenski I; Mazneĭkova V; Mikhaĭlova E; Simeonov E; Tincheva R; Toncheva D
    Akush Ginekol (Sofiia); 2002; 41(2):3-12. PubMed ID: 12066548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
    Christiansen M; Høgdall EV; Larsen SO; Høgdall C
    Prenat Diagn; 2002 May; 22(5):385-7. PubMed ID: 12001192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First trimester screening for Down syndrome in rhesus negative women.
    Muhcu M; Mungen E; Atay V; Ipcioglu OM; Dundar O; Ergur R; Yergok YZ
    Prenat Diagn; 2008 May; 28(5):404-7. PubMed ID: 18318000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship of adverse pregnancy outcomes and a high risk serum screen for Down syndrome in the second trimester].
    Hu XY; Bian XM; Jiang YL; Liu SY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):427-30. PubMed ID: 22932108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. hCG and the free beta-subunit as screening tests for Down syndrome.
    Knight GJ; Palomaki GE; Neveux LM; Fodor KK; Haddow JE
    Prenat Diagn; 1998 Mar; 18(3):235-45. PubMed ID: 9556040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
    Lambert-Messerlian G; Dugoff L; Vidaver J; Canick JA; Malone FD; Ball RH; Comstock CH; Nyberg DA; Saade G; Eddleman K; Klugman S; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
    Prenat Diagn; 2006 Aug; 26(8):672-8. PubMed ID: 16764012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does vaginal bleeding influence first-trimester markers for Down syndrome?
    Heinig J; Steinhard J; Schmitz R; Nofer JR; Witteler R; Mosel A; Ahrens A; Kiesel L; Klockenbusch W
    Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
    Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
    Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
    Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
    Räty R; Anttila L; Virtanen A; Koskinen P; Laitinen P; Mörsky P; Tiitinen A; Martikainen H; Ekblad U
    Prenat Diagn; 2003 Dec; 23(13):1045-8. PubMed ID: 14691989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
    Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.